5-Methoxyisoindoline is a reagent used in the sysnthesis of PDK inhibitors for used in targetting glucose and fat levels in type 2 diabetes. Also used in the preparation of C20’ ureas based on 20’amino-vinblastine for use against vinblastine-resistant cancer cell lines.